NO974400L - Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan - Google Patents

Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Info

Publication number
NO974400L
NO974400L NO974400A NO974400A NO974400L NO 974400 L NO974400 L NO 974400L NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 L NO974400 L NO 974400L
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
formula
preparations containing
combination preparations
Prior art date
Application number
NO974400A
Other languages
English (en)
Other versions
NO974400D0 (no
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400D0 publication Critical patent/NO974400D0/no
Publication of NO974400L publication Critical patent/NO974400L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det er beskrevet f armasizytlske kombinasjonspreparater for behandlingen av hypertensjon, kongestlv hjertefeil og nyresvikt, Innbefattende (1) ACE-lnhibltoren benazeprll av formel (I) eller benazeprilat av formel (II) eller et farmasøytisk akseptabelt salt derav, og (2) ATj^-antagonlsten valsartan av formel (III) eller et farmasizytlsk akseptabelt salt derav, såvel som fremgangsmåter for behandling av hypertensjon, kongestlv hjertefeil og nyresvikt.
NO974400A 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan NO974400L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400D0 NO974400D0 (no) 1997-09-23
NO974400L true NO974400L (no) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400L (no) 1995-04-07 1997-09-23 Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (no)
JP (1) JPH11503139A (no)
KR (1) KR19980703647A (no)
CN (1) CN1181019A (no)
AU (1) AU5399096A (no)
BR (1) BR9604818A (no)
CA (1) CA2214143A1 (no)
CZ (1) CZ313897A3 (no)
HU (1) HUP9801593A2 (no)
MX (1) MX9707683A (no)
NO (1) NO974400L (no)
PL (1) PL322529A1 (no)
SK (1) SK133897A3 (no)
TR (1) TR199701121T1 (no)
WO (1) WO1996031234A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224451A1 (en) * 1995-06-30 1997-01-23 Merck & Co., Inc. Method of treating renal disease using an ace inhibitor and an aii antagonist
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CA2405793A1 (en) * 2000-04-12 2001-10-18 Novartis Ag Combination of organic compounds
BR0112665A (pt) 2000-07-19 2003-06-24 Novartis Ag Sais
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
EE200300075A (et) * 2000-08-22 2004-12-15 Boehringer Ingelheim Pharma Kg Angiotensiin II antagonistide ja ACE inhibiitorite farmatseutiline kombinatsioon
MXPA03005462A (es) * 2000-12-18 2003-09-25 Novartis Ag Combinacion terapeutica de amlodipina y benazepril.
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
EP1578360A4 (en) * 2002-08-28 2009-10-21 Curis Inc JOINT ADMINISTRATION OF MORPHOGENES AND ANGIOTENSIN ENZYME CONVERTING INHIBITORS FOR THE TREATMENT OF CHRONIC RENAL FAILURE
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
SG176585A1 (en) 2009-05-20 2012-01-30 Boehringer Ingelheim Vetmed Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
WO2015116880A1 (en) * 2014-01-31 2015-08-06 Janssen Pharmaceutica Nv Methods for the treatment and prevention of renal disorders and fatty liver disorders
EP3996709A1 (en) 2019-07-09 2022-05-18 Boehringer Ingelheim Vetmedica GmbH Telmisartan for the treatment of hypertension in dogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2147875C1 (ru) * 1990-05-11 2000-04-27 Пфайзер Инк. Способ и композиция для снижения кровяного давления и лечения застойной сердечной недостаточности у млекопитающего
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
TR199701121T1 (xx) 1998-03-21
AU5399096A (en) 1996-10-23
NO974400D0 (no) 1997-09-23
CZ313897A3 (cs) 1998-01-14
BR9604818A (pt) 1998-06-09
PL322529A1 (en) 1998-02-02
SK133897A3 (en) 1998-02-04
MX9707683A (es) 1997-12-31
CN1181019A (zh) 1998-05-06
HUP9801593A2 (hu) 1999-01-28
EP0820302A1 (en) 1998-01-28
JPH11503139A (ja) 1999-03-23
WO1996031234A1 (en) 1996-10-10
KR19980703647A (ko) 1998-12-05
CA2214143A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
GB9914486D0 (en) Medicaments
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
DE69831868D1 (en) Antithrombosemittel
CA2216796A1 (en) Quinazoline derivatives
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
DE69830504D1 (de) Antithrombotische mitteln
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
DK0951474T3 (da) Nye cyclosporinderivater, deres fremstilling og farmaceutiske præparater deraf
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU3664401A (en) Platelet adp receptor inhibitors
RU94044677A (ru) Трехзамещенные фенильные производные, способ получения, фармацевтическая композиция
DE69705300D1 (de) Cyclopropylalkansäurederivate
DE69530081D1 (de) Gastrin- und cck-antagonisten
ATE194335T1 (de) 4,5-diaryloxazol-derivate
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
MX9707683A (es) Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.
MX9704856A (es) Derivados de indazol sustituidos.
FI973691A7 (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäv iä koostumuksia
NO20001515L (no) Vitronektin reseptor-antagonist